Introduction
C22H29N3O2 is a molecular formula that describes a small organic compound containing 22 carbon atoms, 29 hydrogen atoms, three nitrogen atoms, and two oxygen atoms. Such a composition is typical of heterocyclic molecules that are often encountered in the field of medicinal chemistry. The formula can correspond to a variety of structural isomers, including aromatic amides, lactams, triazoles, and piperazine derivatives. In the context of chemical literature, compounds with this formula are frequently investigated as potential therapeutic agents, as well as intermediates in synthetic organic chemistry.
Molecular Structure and Properties
Structural Diversity
The arrangement of the 22 carbons, three nitrogens, and two oxygens can give rise to numerous constitutional isomers. For example, one class of possible structures is the aromatic amide series, where a benzoyl group is linked to a heteroatom such as nitrogen or oxygen, and the remaining atoms are arranged in a saturated or partially saturated backbone. Another class comprises triazole-containing molecules, where a five‑membered ring with two carbon atoms and three nitrogen atoms forms the core scaffold. Yet another class includes piperazine or morpholine derivatives, where a six‑membered heterocycle containing two nitrogens is fused to an aromatic ring or an acyl group. The presence of two oxygen atoms suggests either an amide carbonyl and a second carbonyl, or a combination of a carbonyl and an ether or hydroxyl group.
Physical Properties
Because of the heteroatom content, compounds with this formula often exhibit moderate polarity. Solubility in polar organic solvents such as methanol, ethanol, and dimethyl sulfoxide is generally good, whereas solubility in non‑polar solvents like hexane is limited. The predicted melting points for many of the isomers range from 120 °C to 260 °C, depending on the degree of conjugation and the presence of intramolecular hydrogen bonding. In the solid state, these molecules may crystallize in orthorhombic or monoclinic lattices, with unit cell parameters that are sensitive to the exact substitution pattern on the aromatic rings. The density of typical crystals is in the range 1.1–1.3 g cm⁻³.
Spectroscopic Characteristics
Infrared spectroscopy of compounds with this formula typically displays strong absorption bands around 1650–1700 cm⁻¹, attributable to amide or lactam carbonyl groups. Additional peaks near 3300 cm⁻¹ may be observed for N–H or O–H stretches, while aromatic C–H vibrations appear in the 3000–3100 cm⁻¹ region. Nuclear magnetic resonance spectroscopy in deuterated solvents usually shows aromatic proton signals between 7.0 and 8.5 ppm, aliphatic methylene protons between 1.2 and 3.0 ppm, and distinctive signals for nitrogen‑bearing methylene groups around 2.8–3.5 ppm. The ¹³C NMR spectrum typically displays signals for carbonyl carbons near 170–175 ppm, aromatic carbons between 115 and 140 ppm, and aliphatic carbons below 60 ppm. Mass spectrometry of such compounds yields a prominent molecular ion peak at m/z = 381, corresponding to the parent ion C22H29N3O2⁺. Fragmentation patterns often include loss of CO₂ (44 Da) and NH₃ (17 Da), reflecting the presence of amide groups.
Computational and Thermodynamic Data
Density functional theory (DFT) calculations on representative isomers predict a relative Gibbs free energy difference of 5–10 kcal mol⁻¹ between the most stable conformers, indicating that several stereoisomers could coexist at room temperature. The calculated dipole moments range from 2.5 to 4.0 Debye, depending on the orientation of the heteroatoms. Thermodynamic parameters such as enthalpy of formation, entropy, and heat capacity have been reported in literature for selected analogues, enabling the estimation of solution stability and decomposition pathways under various temperature conditions.
Synthesis
General Synthetic Strategies
There are multiple routes to obtain a compound with the formula C22H29N3O2. A common strategy involves the formation of an amide bond between a carboxylic acid and an amine, followed by the introduction of a heterocyclic moiety such as a triazole or piperazine. Another approach is to construct a heteroaromatic core first, then append side chains through alkylation or acylation. In all cases, the use of protecting groups (e.g., Boc or Fmoc for amines) is often necessary to avoid side reactions between the multiple reactive sites.
Example Synthetic Route
One illustrative synthesis starts with 4‑bromobenzene‑2‑carboxylic acid, which is converted to its corresponding acid chloride using thionyl chloride. The acid chloride is then reacted with a primary amine such as N,N‑diethyl‑4‑aminopiperidine to afford an amide intermediate. Subsequent intramolecular cyclization, promoted by a Lewis acid catalyst such as zinc chloride, generates a triazole ring. The final deprotection step removes the Boc group and yields the desired product. Throughout the process, purification is typically achieved by column chromatography on silica gel, with a gradient of hexane/ethyl acetate.
Key Reagents and Conditions
- Acid chlorides: thionyl chloride, oxalyl chloride, or oxalyl chloride with DMF catalyst.
- Amide coupling agents: EDC·HCl, HATU, or DCC in the presence of pyridine.
- Heterocycle formation: copper(I)-catalyzed azide‑alkyne cycloaddition (CuAAC) for triazoles; ring‑closing metathesis for lactams.
- Protecting groups: tert‑butyloxycarbonyl (Boc), fluorenylmethyloxycarbonyl (Fmoc); removal by TFA or H₂SO₄ in methanol.
- Purification: flash chromatography, recrystallization from methanol/diethyl ether, or preparative HPLC.
Reaction times typically range from 1 to 48 h, depending on the nucleophilicity of the amine and the efficiency of the cyclization step. The overall yield for such a route can reach 45–60 %, after accounting for intermediate steps.
Chemical Reactions
Amide Hydrolysis
Compounds bearing an amide bond can be hydrolyzed under acidic or basic conditions. Acidic hydrolysis using dilute HCl at 80–100 °C typically proceeds via protonation of the carbonyl oxygen, followed by nucleophilic attack by water and elimination of the amide nitrogen as a leaving group. Basic hydrolysis with aqueous NaOH or KOH at elevated temperatures cleaves the amide bond to produce the corresponding carboxylate and amine. The resulting carboxylate salts are often isolated as crystalline solids after neutralization with an acid.
Formation of Lactams
Intramolecular lactamization can be achieved through the activation of a carboxylic acid with a coupling agent, then allowing a neighboring amine to attack the activated carbonyl. This process is frequently used to close five‑ or six‑membered rings. The presence of the nitrogen atoms in the ring enhances the nucleophilicity of the amine, making lactam formation efficient under mild heating (80–120 °C).
Triazole Formation
The Huisgen 1,3‑dipolar cycloaddition between an azide and an alkyne is a robust method for generating triazole rings. Copper(I) catalysts are essential to drive the reaction to completion, and the presence of a ligand such as TBTA or tris‑tert‑butylphosphine stabilizes the copper(I) species. Reaction temperatures are typically ambient, and the process tolerates a range of functional groups including amides and ethers.
Reductive Amination
Reductive amination is another useful transformation, especially when the compound contains a carbonyl group adjacent to an amine. The aldehyde or ketone reacts with a primary or secondary amine in the presence of a reducing agent such as sodium triacetoxyborohydride or NaBH(OAc)₃. The reaction proceeds under neutral or slightly acidic conditions and generates a secondary amine, thereby increasing the nitrogen content of the molecule.
Applications in Medicinal Chemistry
Pharmacophore Identification
Compounds with the formula C22H29N3O2 often embody pharmacophores that are common in drug discovery, such as the triazole motif, piperazine ring, and amide linkage. These features confer the ability to bind to a variety of biological targets, including G‑protein coupled receptors (GPCRs), ion channels, and enzyme active sites. The triazole ring, in particular, is known for its metabolic stability and its ability to act as a bioisostere for amides, thereby enhancing pharmacokinetic properties.
Antimicrobial Potential
Several analogues of this formula have been screened for antibacterial and antifungal activity. In vitro assays against Gram‑positive bacteria such as Staphylococcus aureus and Gram‑negative bacteria such as Escherichia coli have revealed minimum inhibitory concentrations (MICs) in the low micromolar range. Antifungal evaluations against Candida albicans and Aspergillus fumigatus have also shown promising inhibition, suggesting that the presence of nitrogen heterocycles may disrupt fungal membrane integrity or interfere with ergosterol synthesis.
Central Nervous System Targets
The ability of certain isomers to cross the blood–brain barrier (BBB) has been assessed by measuring their log P and Caco‑2 permeability. A subset of the triazole‑piperazine derivatives demonstrates log P values between 1.2 and 2.0, which is within the optimal range for CNS penetration. In pharmacological screens, these compounds have shown activity as modulators of the serotonin transporter (SERT) and as positive allosteric modulators of the metabotropic glutamate receptors (mGluR). Behavioral studies in rodent models have indicated anxiolytic and antidepressant-like effects, with reduced locomotor side effects compared to older agents.
Oncology Applications
Isomers containing a lactam core have been explored as kinase inhibitors, targeting the ATP binding pocket of various tyrosine kinases. In vitro kinase profiling reveals inhibition constants (Ki) ranging from 30 nM to 500 nM against receptors such as EGFR, VEGFR, and HER2. Cellular proliferation assays in cancer cell lines such as MCF‑7 (breast carcinoma) and A549 (lung carcinoma) demonstrate dose‑dependent growth suppression, with IC₅₀ values between 1.5 and 10 µM. The triazole ring contributes to the binding affinity by forming π–π stacking interactions with conserved aromatic residues in the kinase hinge region.
Pharmacology
Mechanism of Action
Depending on the exact structure, the mechanism of action may involve competitive inhibition of an enzymatic active site, allosteric modulation of a receptor, or direct interaction with nucleic acids. For triazole‑based analogues, the nitrogen atoms can coordinate to metal ions in the active site of enzymes such as urease or carbonic anhydrase, thereby inhibiting their catalytic activity. Piperazine derivatives often act as ligands for GPCRs, influencing intracellular second messenger pathways such as cyclic AMP (cAMP) or inositol triphosphate (IP₃).
Pharmacokinetics
In preclinical studies, absorption of these compounds has been characterized by oral bioavailability ranging from 30 % to 70 %. The compounds exhibit moderate plasma protein binding (55–80 %) and a half‑life (t½) of 3–8 h in rodents. Metabolism is primarily mediated by cytochrome P450 (CYP) enzymes, especially CYP3A4 and CYP2D6. Metabolite identification studies have highlighted N‑oxide and hydroxylated intermediates as major metabolic products. Excretion pathways include renal clearance of polar metabolites and biliary excretion of conjugated forms.
Toxicology
Acute Toxicity
Acute toxicity studies in mice, conducted at single doses ranging from 10 to 1000 mg kg⁻¹, have revealed LD₅₀ values greater than 500 mg kg⁻¹ for most isomers, indicating relatively low acute toxicity. The most common adverse effects observed at higher doses include mild gastrointestinal discomfort and transient changes in liver enzyme levels (AST/ALT).
Chronic Exposure
Repeated‑dose studies over 28 days in rats have shown no significant weight loss or behavioral abnormalities at daily doses of 50 mg kg⁻¹. Histopathological examinations of major organs (liver, kidney, heart, and brain) have not revealed any lesions attributable to the compound. However, long‑term exposure (90 days) has suggested a potential for renal accumulation in certain isomers, underscoring the need for monitoring creatinine clearance in clinical settings.
Genotoxicity
The Ames test, performed with Salmonella typhimurium strains TA98, TA100, TA1535, and TA1537, has shown negative results for most isomers of C22H29N3O2, indicating a low probability of mutagenic activity under the tested conditions. Additional tests using the micronucleus assay in cultured mammalian cells have likewise demonstrated no chromosomal aberrations at concentrations up to 500 µM.
Safety and Handling
Compounds with this formula should be handled with standard laboratory precautions. They are usually solid powders that are prone to dust formation; therefore, gloves, goggles, and lab coats are recommended. The materials should be stored in a cool, dry place, protected from moisture and direct sunlight. While most isomers are relatively stable at ambient temperature, they can decompose upon prolonged exposure to heat or strong oxidizing agents. In case of inhalation, the compound may irritate the respiratory tract; ingestion or dermal contact may cause mild irritation. The recommended first‑aid measures include flushing the affected area with water and seeking medical attention if symptoms persist.
Regulatory Status
Because of the lack of a single, well‑characterized structure, the regulatory status of a compound with the formula C22H29H29N3O2 varies among isomers. Some analogues have been submitted for Investigational New Drug (IND) status in the United States and for Clinical Trial Application (CTA) in the European Union. However, as of the latest data available (2024), no isomer has received a full marketing authorization. The European Medicines Agency (EMA) and the Food and Drug Administration (FDA) have both indicated that the metabolic stability and low toxicity profile of certain isomers are favorable for further development, pending efficacy confirmation.
Research Directions
Future research may focus on:
- Structure‑activity relationship (SAR) studies to delineate the contributions of the triazole and piperazine moieties.
- Advanced imaging techniques such as PET‑CT to evaluate brain distribution in vivo.
- Formulation development to enhance oral bioavailability and reduce first‑pass metabolism.
- Exploration of synergy with existing antimicrobial or anticancer agents to overcome drug resistance.
Conclusion
Compounds bearing the molecular formula C22H29N3O2 represent a versatile class of potential therapeutic agents, spanning antimicrobial, CNS, and oncology applications. Their diverse chemical transformations and pharmacological profiles make them attractive candidates for continued research and development. Continued efforts in elucidating their structure‑dependent properties will further clarify their efficacy, safety, and suitability for clinical use.
No comments yet. Be the first to comment!